Trade Summary

1 week ago, Pauwels Eric, serving as CHIEF BUSINESS OFFICER at Ptc Therapeutics, Inc. (PTCT), sold 20,508 shares at $77.26 per share, for a total transaction value of $1,584,350.00. Following this transaction, Pauwels Eric now holds 70,373 shares of PTCT.

This sale represents a 23.00% decrease in Pauwels Eric's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Ptc Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.